Skip to content

Predictive value of combination of enhanced MRI and neutrophil to lymphocyte ratio in nodal status of breast cancer patients with clinical negative lymph node after neoadjuvant treatment

Predictive value of combination of enhanced MRI and neutrophil to lymphocyte ratio in nodal status of breast cancer patients with clinical negative lymph node after neoadjuvant treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067448
Enrollment
Unknown
Registered
2023-01-09
Start date
2023-01-20
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Case series:None

Sponsors

the Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: all the criteria below should be fulfilled at the same time: 1. patients with cT1-4, cN0 breast cancer who received neoadjuvant treatment followed by SLNB with/without ALND 2. ultrasound and MRI before and after NAT available 3. imaging-guided fine needle aspiration (FNA) was necessary when suspicious lymph nodes indicated. Clinical lymph node negativity before NST is defined as no suspicion of metastasis to lymph node based on imaging results or negative result of a FNA for relevant suspicious lymph nodes. 4. patients with available peripheral blood test before any breast cancer treatment and before the definitive operation

Exclusion criteria

Exclusion criteria: 1. metastatic disease (stage IV) or bilateral breast cancer; 2. previous systemic or local anticancer therapy; 3. other malignancy

Design outcomes

Primary

MeasureTime frame
result of nodal status in definitive operation;

Countries

People's republic of China

Contacts

Public ContactHuaiquan Zuo

the Affiliated Hospital of Southwest Medical University

Brustchirurg@163.com+86 13982772996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026